Hypoactive sexual desire disorder (HSDD) is the absence of sexual thoughts and fantasies causing low libido and sex drive in women population worldwide.

The global Hypoactive Sexual Desire Disorder (HSDD) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Hypoactive Sexual Desire Disorder (HSDD) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypoactive Sexual Desire Disorder (HSDD) Treatment.

Report Scope

The Hypoactive Sexual Desire Disorder (HSDD) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hypoactive Sexual Desire Disorder (HSDD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Report

Report Metric	Details
Report Name	Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
CAGR	5%
Segment by Type	Buspirone Bupropion Testosterone Flibanserin Bremelanotide Cognitive Behavior Therapy
Segment by Application	Hospitals Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AMAG Pharmaceuticals, Allergan, Plc., Ivix LLX, EndoCeutics, Inc., Emotional Brain BV, S1 Biopharma, Inc., Sprout Pharmaceuticals, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hypoactive Sexual Desire Disorder (HSDD) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report?

Ans: The main players in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market are AMAG Pharmaceuticals, Allergan, Plc., Ivix LLX, EndoCeutics, Inc., Emotional Brain BV, S1 Biopharma, Inc., Sprout Pharmaceuticals, Inc.

What are the Application segmentation covered in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report?

Ans: The Applications covered in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report?

Ans: The Types covered in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report are Buspirone, Bupropion, Testosterone, Flibanserin, Bremelanotide, Cognitive Behavior Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Buspirone

1.2.3 Bupropion

1.2.4 Testosterone

1.2.5 Flibanserin

1.2.6 Bremelanotide

1.2.7 Cognitive Behavior Therapy

1.3 Market by Application

1.3.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Perspective (2019-2030)

2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Trends by Region

2.2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Region (2019-2024)

2.2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Region (2025-2030)

2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Dynamics

2.3.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Industry Trends

2.3.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers

2.3.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges

2.3.4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue

3.1.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue (2019-2024)

3.1.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue

3.4 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio

3.4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2023

3.5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players Head office and Area Served

3.6 Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service

3.7 Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Type

4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Type (2019-2024)

4.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2025-2030)

5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Application

5.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Application (2019-2024)

5.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2019-2030)

6.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024)

6.4 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2019-2030)

7.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024)

7.4 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2019-2030)

8.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2019-2030)

9.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024)

9.4 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2019-2030)

10.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AMAG Pharmaceuticals

11.1.1 AMAG Pharmaceuticals Company Detail

11.1.2 AMAG Pharmaceuticals Business Overview

11.1.3 AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction

11.1.4 AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

11.1.5 AMAG Pharmaceuticals Recent Development

11.2 Allergan, Plc.

11.2.1 Allergan, Plc. Company Detail

11.2.2 Allergan, Plc. Business Overview

11.2.3 Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction

11.2.4 Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

11.2.5 Allergan, Plc. Recent Development

11.3 Ivix LLX

11.3.1 Ivix LLX Company Detail

11.3.2 Ivix LLX Business Overview

11.3.3 Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction

11.3.4 Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

11.3.5 Ivix LLX Recent Development

11.4 EndoCeutics, Inc.

11.4.1 EndoCeutics, Inc. Company Detail

11.4.2 EndoCeutics, Inc. Business Overview

11.4.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction

11.4.4 EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

11.4.5 EndoCeutics, Inc. Recent Development

11.5 Emotional Brain BV

11.5.1 Emotional Brain BV Company Detail

11.5.2 Emotional Brain BV Business Overview

11.5.3 Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction

11.5.4 Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

11.5.5 Emotional Brain BV Recent Development

11.6 S1 Biopharma, Inc.

11.6.1 S1 Biopharma, Inc. Company Detail

11.6.2 S1 Biopharma, Inc. Business Overview

11.6.3 S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction

11.6.4 S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

11.6.5 S1 Biopharma, Inc. Recent Development

11.7 Sprout Pharmaceuticals, Inc.

11.7.1 Sprout Pharmaceuticals, Inc. Company Detail

11.7.2 Sprout Pharmaceuticals, Inc. Business Overview

11.7.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction

11.7.4 Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

11.7.5 Sprout Pharmaceuticals, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Sprout Pharmaceuticals Inc.

List of Tables

Table 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Buspirone

Table 3. Key Players of Bupropion

Table 4. Key Players of Testosterone

Table 5. Key Players of Flibanserin

Table 6. Key Players of Bremelanotide

Table 7. Key Players of Cognitive Behavior Therapy

Table 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2019-2024)

Table 12. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2025-2030)

Table 14. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Trends

Table 15. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers

Table 16. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges

Table 17. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints

Table 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players (2019-2024)

Table 20. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2023)

Table 21. Ranking of Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service

Table 25. Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2019-2024)

Table 29. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2025-2030)

Table 31. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Application (2019-2024)

Table 33. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Application (2025-2030)

Table 35. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 50. AMAG Pharmaceuticals Company Detail

Table 51. AMAG Pharmaceuticals Business Overview

Table 52. AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Product

Table 53. AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)

Table 54. AMAG Pharmaceuticals Recent Development

Table 55. Allergan, Plc. Company Detail

Table 56. Allergan, Plc. Business Overview

Table 57. Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product

Table 58. Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)

Table 59. Allergan, Plc. Recent Development

Table 60. Ivix LLX Company Detail

Table 61. Ivix LLX Business Overview

Table 62. Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Product

Table 63. Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)

Table 64. Ivix LLX Recent Development

Table 65. EndoCeutics, Inc. Company Detail

Table 66. EndoCeutics, Inc. Business Overview

Table 67. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product

Table 68. EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)

Table 69. EndoCeutics, Inc. Recent Development

Table 70. Emotional Brain BV Company Detail

Table 71. Emotional Brain BV Business Overview

Table 72. Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Product

Table 73. Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)

Table 74. Emotional Brain BV Recent Development

Table 75. S1 Biopharma, Inc. Company Detail

Table 76. S1 Biopharma, Inc. Business Overview

Table 77. S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product

Table 78. S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)

Table 79. S1 Biopharma, Inc. Recent Development

Table 80. Sprout Pharmaceuticals, Inc. Company Detail

Table 81. Sprout Pharmaceuticals, Inc. Business Overview

Table 82. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product

Table 83. Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)

Table 84. Sprout Pharmaceuticals, Inc. Recent Development

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type: 2023 VS 2030

Figure 3. Buspirone Features

Figure 4. Bupropion Features

Figure 5. Testosterone Features

Figure 6. Flibanserin Features

Figure 7. Bremelanotide Features

Figure 8. Cognitive Behavior Therapy Features

Figure 9. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2023 VS 2030

Figure 11. Hospitals Case Studies

Figure 12. Clinic Case Studies

Figure 13. Others Case Studies

Figure 14. Hypoactive Sexual Desire Disorder (HSDD) Treatment Report Years Considered

Figure 15. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region: 2023 VS 2030

Figure 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players in 2023

Figure 19. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2023

Figure 21. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2019-2030)

Figure 23. United States Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2019-2030)

Figure 27. Germany Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2019-2030)

Figure 35. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2019-2030)

Figure 43. Mexico Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2019-2030)

Figure 47. Turkey Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. AMAG Pharmaceuticals Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

Figure 50. Allergan, Plc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

Figure 51. Ivix LLX Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

Figure 52. EndoCeutics, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

Figure 53. Emotional Brain BV Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

Figure 54. S1 Biopharma, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

Figure 55. Sprout Pharmaceuticals, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions